[{"NetIncomeLoss_1_Q1_USD":-20402000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4605000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":169659037.0,"CommitmentsAndContingencies_0_Q1_USD":null,"InterestIncomeOther_1_Q1_USD":438000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":3984000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":981000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-1085000.0,"DepreciationAndAmortization_1_Q1_USD":30000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":3787000.0,"MarketableSecuritiesRealizedGainLoss_1_Q1_USD":-45000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_1_Q1_USD":5.0,"MarketRiskBenefitChangeInFairValueGainLoss_1_Q1_USD":300000.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"CommonStockSharesIssued_0_Q1_shares":217650055.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":185809000.0,"BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses_1_Q1_USD":624964000.0,"AssetsCurrent_0_Q1_USD":830866000.0,"Assets_0_Q1_USD":832059000.0,"MarketableSecuritiesCurrent_0_Q1_USD":185809000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":638904000.0,"AdjustmentForAmortization_1_Q1_USD":600000.0,"PrepaidExpenseCurrent_0_Q1_USD":5138000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-701000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":null,"CommonStockValue_0_Q1_USD":901720000.0,"WarrantsAndRightsOutstanding_0_Q1_USD":15561000.0,"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0_Q1_USD":312000.0,"Liabilities_0_Q1_USD":25715000.0,"IncreaseDecreaseInInterestAndDividendsReceivable_1_Q1_USD":-77000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":624964000.0,"DerivativeFairValueOfDerivativeLiability_0_Q1_USD":15561000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":23542000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q1_shares":5787472.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":293000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-20978000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":3940000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q1_USD":54013000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":3913000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-576000.0,"ProfessionalFees_1_Q1_USD":108000.0,"CommonStockSharesOutstanding_0_Q1_shares":217650055.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":24513000.0,"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_0_Q1_USD":-601000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":981000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-20402000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1566000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":-531000.0,"PaymentsToAcquireMachineryAndEquipment_1_Q1_USD":114000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":14730000.0,"AccountsPayableCurrent_0_Q1_USD":6003000.0,"NonoperatingIncomeExpense_1_Q1_USD":82000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_1_Q1_pure":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":638904000.0,"StockIssued1_1_Q1_USD":3787000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q1_USD":11.5,"PropertyPlantAndEquipmentNet_0_Q1_USD":772000.0,"LiabilitiesCurrent_0_Q1_USD":9987000.0,"ShareBasedCompensation_1_Q1_USD":1566000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":609149000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":96357000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q1_USD":131796000.0,"CommonStockSharesAuthorized_0_Q1_shares":1060000000.0,"OperatingIncomeLoss_1_Q1_USD":-20484000.0,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0_Q1_USD":185809000.0,"PaymentsToAcquireHeldToMaturitySecurities_1_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":832059000.0,"MarketableSecurities_0_Q1_USD":185809000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1566000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.12,"ProfitLoss_1_Q1_USD":-20402000.0,"UnrealizedGainLossOnSecurities_1_Q1_USD":-576000.0,"StockholdersEquity_0_Q1_USD":806344000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":184828000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":167000.0,"DeferredCostsCurrent_0_Q1_USD":0.0,"OperatingExpenses_1_Q1_USD":20484000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":15879000.0,"Ticker":"NUVB","CIK":"1811063","name":"NUVATION BIO INC.","OfficialName":"Nuvation Bio Inc. Class A Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1238973430.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210517"}]